Summary
Liraglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1). This article discusses phase 3 trials where this agent shows promise for the treatment of type 2 diabetes.
- endocrinology
- diabetes & metabolic syndrome
- diabetes & endocrinology clinical trials
- diabetes mellitus
- © 2006 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.